This annual session is an opportunity for all interested stakeholders to get the latest information about priority initiatives and process changes from the CADTH pharmaceutical reviews portfolio. Updates on other relevant CADTH initiatives will also be provided. As well, the session includes an…
Health technology assessment (HTA) plays a key role in decisions about the use of medical devices in Canada. This session will cover the role of HTA in the management of medical devices in Canada, the programs in CADTH’s medical devices and clinical interventions portfolio, and CADTH’s COVID-19…
Before COVID-19, virtual care was a topic of interest to many Canadians, but widespread uptake felt stubbornly out of reach. The pandemic changed everything and the delivery of virtual care surged almost overnight.
Health care providers, policy-makers, and patients are wondering if we can sustain…
Connect with Canadian and international experts for two days of education, information sharing, and networking on the objective assessment and evaluation of health technologies.
The landscape of scientific publishing has shifted during the pandemic. Many publishers have made research related to COVID-19 freely available, preprint servers have surged in popularity to share new results ahead of formal publication, journals have expedited their publication processes, and…
Around the world, governments, researchers, and health care providers are working under extreme pressure to develop and deliver effective, evidence-based approaches to prevent, detect, treat, and manage COVID-19. The need for swift action combined with the constantly changing information we have…
Because of the prevalence and burden of chronic pain, health care providers are in search of the best multifaceted approach for treatment knowing that relying on opioids alone can be ineffective and carries substantial risks. Join CADTH for a webinar on the current evidence on physical activity for…
With the COVID-19 pandemic showing no signs of slowing down, there’s a lot of interest in the global effort to develop a vaccine. Below the radar, researchers are exploring many other treatment options, including a century-old therapy that has been used to combat outbreaks of polio, measles, mumps…
The COVID-19 pandemic has disrupted our lives. Medical experts around the globe have said that what we each have known as normal life won’t fully resume until we have a vaccine, and that could take years. In this webinar, an expert panel will take you inside the race to develop a COVID-19 vaccine.…
Pharmaceutical companies and other stakeholders are invited to comment on a revised procedure for CADTH’s drug reimbursement review processes (that is, the pan-Canadian Oncology Drug Review, the Common Drug Review, the Interim Plasma Protein Product Review, and the Interim Process for Cell and Gene…